- Home
- Publications
- Publication Search
- Publication Details
Title
Current and future molecular diagnostics of gastric cancer
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 19, Issue 10, Pages 863-874
Publisher
Informa UK Limited
Online
2019-08-26
DOI
10.1080/14737159.2019.1660645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
- (2019) Hui Cai et al. Journal of Translational Medicine
- HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
- (2018) Haixing Wang et al. EUROPEAN JOURNAL OF CANCER
- Biomarkers of gastric cancer: Current topics and future perspective
- (2018) Tasuku Matsuoka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Helicobacter Pylori Promotes Cisplatin Resistance in Gastric Cancer VIA Long Noncoding RNA H19/MIR-675/FADD Pathway
- (2017) Jin Yan GASTROENTEROLOGY
- High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survival
- (2017) Daiyong Wang et al. Oncology Letters
- The role of miRNA and lncRNA in gastric cancer
- (2017) Ning-Bo Hao et al. Oncotarget
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Molecular classification of gastric cancer
- (2016) N.-Y. Chia et al. ANNALS OF ONCOLOGY
- Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?
- (2016) Ammad Ahmad Farooqi et al. Chemical Biology & Drug Design
- High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study
- (2016) Masahiro Maeda et al. GUT
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
- (2016) Yelena Y. Janjigian JOURNAL OF CLINICAL ONCOLOGY
- MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer
- (2016) Ran Tang et al. Oncotarget
- Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
- (2016) Jingjing Duan et al. Oncotarget
- MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
- (2015) M Pichler et al. BRITISH JOURNAL OF CANCER
- Droplet digital PCR measurement of HER2 in patients with gastric cancer
- (2015) H Kinugasa et al. BRITISH JOURNAL OF CANCER
- miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT
- (2015) Dan Zhang et al. CANCER LETTERS
- Gene mutations in gastric cancer: a review of recent next-generation sequencing studies
- (2015) Y. Lin et al. TUMOR BIOLOGY
- Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review)
- (2015) ZILIANG JIN et al. Oncology Letters
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Clinical significance of MET in gastric cancer
- (2015) Mikito Inokuchi World Journal of Gastrointestinal Oncology
- Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer
- (2014) M. Alsina et al. ANNALS OF ONCOLOGY
- MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer
- (2014) Jianhong Wu et al. BIOMARKERS
- miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2–STAT3 signaling
- (2014) Lin Miao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis
- (2014) Jian-Guo Wu et al. Gastric Cancer
- Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
- (2014) Kiyoshi Asada et al. GUT
- Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations
- (2014) SANDY CHEVRIER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening
- (2014) Hui Wang et al. MEDICAL ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase
- (2014) L Chen et al. Cell Death & Disease
- FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
- (2013) L. Xie et al. CLINICAL CANCER RESEARCH
- miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells
- (2013) Yixuan Liu et al. DNA REPAIR
- The Role of microRNA in Gastric Malignancy
- (2013) Toshihiro Nishizawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk
- (2013) Ryo Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Absolute quantification by droplet digital PCR versus analog real-time PCR
- (2013) Christopher M Hindson et al. NATURE METHODS
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
- (2012) M. Terashima et al. CLINICAL CANCER RESEARCH
- Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells
- (2012) Feng Yang et al. FEBS Journal
- Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
- (2012) Bo-sheng Li et al. PLoS One
- Genetic Aspects of Gastric Cancer Instability
- (2012) Petra Hudler TheScientificWorldJOURNAL
- Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer
- (2011) Hanshao Liu et al. CANCER LETTERS
- The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim
- (2009) Takatsugu Kan et al. GASTROENTEROLOGY
- Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
- (2008) Qing Ji et al. BMC CANCER
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started